Denali Therapeutics Inc. Stock Forecast
Explanation to Bollinger's Bands
Bollinger Bands was created by John Bollinger in the early 1980s, its purpose is to define price action relative to the assets highs and lows. This technical indicator is used to identify buy and sell signals and has proven very well in doing so.
Bollinger Bands consist of a set of three curves drawn in relation to securities prices. The middle band is a measure of the intermediate-term trend, usually a simple moving average, that serves as the base for the upper and lower bands. The interval between the upper and lower bands and the middle band is determined by volatility, typically the standard deviation of the same data that were used for the average. StockInvest.us uses Bollingers suggested 20 day average.
Middle Bollinger Band = 20-period simple moving average
Upper Bollinger Band = Middle Bollinger Band + 2 * 20-period standard deviation
Lower Bollinger Band = Middle Bollinger Band - 2 * 20-period standard deviation
BandWidth defines the current width of the band.
%b defines the current position within the band.
BandWidth = (Upper Bollinger Band - Lower Bollinger Band) / Middle Bollinger Band
%b = (Last - Lower Bollinger Band) / (Upper Bollinger Band - Lower Bollinger Band)
Live Samples:
Bottlenecks in bandwidth indicate an upcoming change. Break up through the moving average line or continuous movements above the moving average line indicate a break up, and vice versa.
Source: http://www.bollingerbands.com
Red day on Wednesday for Denali Therapeutics Inc.
(Updated on Apr 24, 2024)
The Denali Therapeutics Inc. stock price fell by -3.41% on the last day (Wednesday, 24th Apr 2024) from $16.11 to $15.56. During the last trading day the stock fluctuated 5.30% from a day low at $15.48 to a day high of $16.30. The price has fallen in 8 of the last 10 days and is down by -15.53% for this period. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -247 thousand shares and in total, 816 thousand shares were bought and sold for approximately $12.69 million.
Given the current short-term trend, the stock is expected to rise 5.51% during the next 3 months and, with a 90% probability hold a price between $16.42 and $25.50 at the end of this 3-month period.
Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.
DNLI Signals & Forecast
There are few to no technical positive signals at the moment. The Denali Therapeutics Inc. stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $16.35 and $19.23. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Tuesday, February 27, 2024, and so far it has fallen -33.36%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell together with the price during the last trading day and this reduces the overall risk as volume should follow the price movements.
Support, Risk & Stop-loss for Denali Therapeutics Inc. stock
There is no support from accumulated volume below today's level and given the right condition the stock may perform very badly in the next couple of days.
This stock may move much during the day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.82 between high and low, or 5.30%. For the last week, the stock has had daily average volatility of 4.66%.
Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.
Trading Expectations (DNLI) For The Upcoming Trading Day Of Thursday 25th
For the upcoming trading day on Thursday, 25th we expect Denali Therapeutics Inc. to open at $15.78, and during the day (based on 14 day Average True Range), to move between $14.67 and $16.45, which gives a possible trading interval of +/-$0.89 (+/-5.72%) up or down from last closing price. If Denali Therapeutics Inc. takes out the full calculated possible swing range there will be an estimated 11.44% move between the lowest and the highest trading price during the day.
With no support below and resistance from accumulated volume @ $15.99, some $0.430 (2.76%) from the current price of $15.56, our system finds the risk reward not very attractive.
Is Denali Therapeutics Inc. stock A Buy?
The Denali Therapeutics Inc. stock holds several negative signals and despite the positive trend, we believe Denali Therapeutics Inc. will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock.
Current score: -1.833 Sell Candidate Unchanged
Predicted Opening Price for Denali Therapeutics Inc. of Thursday, April 25, 2024
| Fair opening price April 25, 2024 | Current price |
|---|---|
| $15.78 ( 1.41%) | $15.56 |
The predicted opening price is based on yesterday's movements between high, low, and closing price.
Trading levels for DNLI
Fibonacci Support & Resistance Levels
| Level | Price | |||
|---|---|---|---|---|
| Resistance | R3 | 16.60 | 6.68 % | |
| R2 | 16.29 | 4.67 % | ||
| R1 | 16.09 | 3.43 % | ||
| Current price: | 15.56 | |||
| Support | S1 | 15.47 | -0.599 % | |
| S2 | 15.27 | -1.84 % | ||
| S3 | 14.96 | -3.86 % |
Accumulated Volume Support & Resistance Levels
| Level | Price | |||
|---|---|---|---|---|
| Resistance | R3 | 17.02 | 9.38 % | |
| R2 | 16.01 | 2.89 % | ||
| R1 | 15.99 | 2.76 % | ||
| Current price | 15.56 | |||
| Support | S1 | 0 | . | |
| S2 | 0 | . | ||
| S3 | 0 | . |
FAQ
Click here for our free guide on how to buy Denali Therapeutics Inc. Stock.
